Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Mandatum Q4’23: Story is on track

MANTA19.02.2024, 15.05
Sara Antonacci, Kasper Mellas
Discuss

Analyst Kasper Mellas comments on Mandatum’s Q4 result, profit distribution, solvency, outlook and guidance as well as our estimates and recommendation at the moment!

Content:
00:00 Intro
00:14 Q4 result
01:32 Profit distribution
02:03 Solvency
03:29 Outlook and guidance
04:03 Estimates and recommendation 

Stay up to date
Analyst Interviews

Upcoming webcasts

Recent videos

Embla Medical – Presentation of the Q3 2026 Interim Report
20.10.2026, 10.30 Embla Medical
HCA Morgenbørs 20/10 - Fokus på Gentoo Media i interview med Michael Hove
20.10.2026, 09.29 DSV
Profoto, Audiocast, Q3'26
20.10.2026, 09.00 Profoto Holding
HCA Morgenbørs 19/10 - Fokus på DSV i interview med Lars Hytting fra Aarthascope
19.10.2026, 09.18 Novo Nordisk
BioPorto: From reaction to prevention in AKI
16.10.2026, 13.13 BioPorto
View all videos